Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study

INTRODUCTION: This analysis evaluated the treatment satisfaction of Japanese patients receiving galcanezumab (GMB) as a preventive medication for episodic migraine (4–14 monthly migraine headache days). METHODS: This phase 2, randomized, double-blind, placebo-controlled study enrolled patients aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsuoka, Yoshihisa, Takeshima, Takao, Ozeki, Akichika, Matsumura, Taka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140173/
https://www.ncbi.nlm.nih.gov/pubmed/33835383
http://dx.doi.org/10.1007/s40120-021-00236-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140173/
https://www.ncbi.nlm.nih.gov/pubmed/33835383
http://dx.doi.org/10.1007/s40120-021-00236-5

Ejemplares similares